Hiroki Maruyama
Impact in
- Nephrology top 2%
- Biotechnology top 5%
- Microbial Inactivation Methods
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 8
- Physiology 23
- Lysosomal Storage Disorders Research 22
- Co-authors
- Jun‐ichi Miyazaki (27 shared papers)Fumitake Gejyo (31 shared papers)Ken Ataka (5 shared papers)Noboru Higuchi (9 shared papers)Junichiro James Kazama (14 shared papers)Kazuhisa Bessho (9 shared papers)Mariko Kawai (10 shared papers)Masaaki Arakawa (11 shared papers)
- Journals
- The Nephron journals/Nephron journals (6 papers)Gene Therapy (4 papers)Human Gene Therapy (3 papers)Chemical Communications (3 papers)Circulation Journal (3 papers)
- Partner nations
- JapanUnited StatesSingapore
In The Last Decade
Hiroki Maruyama
112 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 130
- Nephrology 289
- Biotechnology 171
- Immunology 362
- Rheumatology 239
- Physiology 357
Countries citing papers authored by Hiroki Maruyama
This map shows the geographic impact of Hiroki Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Maruyama more than expected).
Fields of papers citing papers by Hiroki Maruyama
This network shows the impact of papers produced by Hiroki Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Maruyama. The network helps show where Hiroki Maruyama may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroki Maruyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 125 | |
| 2 | 2003 | 107 | |
| 3 | 1983 | 99 | |
| 4 | 2006 | 98 | |
| 5 | 2002 | 80 | |
| 6 | 2001 | 74 | |
| 7 | 2000 | 73 | |
| 8 | 1993 | 68 | |
| 9 | 2001 | 65 | |
| 10 | 2001 | 63 | |
| 11 | 2002 | 62 | |
| 12 | 1992 | 51 | |
| 13 | 2013 | 49 | |
| 14 | 2003 | 48 | |
| 15 | 2006 | 47 | |
| 16 | 2008 | 45 | |
| 17 | 2020 | 44 | |
| 18 | 2003 | 42 | |
| 19 | 2016 | 38 | |
| 20 | Indications for local excision of ampullary lesions associated with familial adenomatous polyposis. | 1994 | 38 |
About Hiroki Maruyama
Hiroki Maruyama is a scholar working on Molecular Biology, Physiology, Nephrology, Organic Chemistry and Genetics, having authored 118 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (22 papers), Virus-based gene therapy research (12 papers), Asymmetric Synthesis and Catalysis (9 papers), Glycogen Storage Diseases and Myoclonus (8 papers), Dialysis and Renal Disease Management (8 papers), Parathyroid Disorders and Treatments (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers) and Carbohydrate Chemistry and Synthesis (7 papers). The work is most often cited by research in Nephrology (289 citations), Biotechnology (171 citations), Immunology (362 citations), Rheumatology (239 citations) and Physiology (357 citations). Hiroki Maruyama has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Jun‐ichi Miyazaki, Fumitake Gejyo, Ken Ataka, Noboru Higuchi, Junichiro James Kazama, Kazuhisa Bessho, Mariko Kawai, Masaaki Arakawa, Shuji Adachi and Kenji Hashimoto. Their work appears in journals such as The Nephron journals/Nephron journals, Gene Therapy, Human Gene Therapy, Chemical Communications and Circulation Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.